Mutational analysis of PTEN/PIK3CA/AKT pathway in oral squamous cell carcinoma

Oral Oncology

Volumn 47, Issue 10, 2011, Pages 946-950

  Cohen, Yoram ^a   Goldenberg Cohen, Nitza ^b   Shalmon, Bruria ^a   Shani, Tali ^a,b   Oren, Shirley ^a   Amariglio, Ninette ^a   Dratviman Storobinsky, Olga ^b   Shnaiderman Shapiro, Anna ^b   Yahalom, Ran ^a   Kaplan, Ilana ^c   Hirshberg, Abraham ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c RABIN MEDICAL CENTER   (Israel)

Author keywords

AKT; Head and neck cancer; Oral cancer; Oral squamous cell carcinoma; PI3K; PTEN; RAS

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE CATALYTIC SUBUNIT; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; RAS PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; FEMALE; GENE MUTATION; GROUPS BY AGE; HUMAN; MALE; MISSENSE MUTATION; MOUTH CARCINOMA; MUTATION RATE; PRIORITY JOURNAL; SMOKING HABIT; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DNA MUTATIONAL ANALYSIS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, RAS; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PHOSPHATIDYLINOSITOL 3-KINASES; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; YOUNG ADULT;

EID: 80054001986     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2011.07.013     Document Type: Article

References (40)

1. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Global cancer statistics, 2002 CA: A Cancer Journal for Clinicians 55 2005 74 108 (Pubitemid 40372904)
2. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics, 2010 CA: A Cancer Journal for Clinicians 60 5 2010 277 300
3. A. Carnero, C. Blanco-Aparicio, O. Renner, W. Link, and J.F.M. Leal The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications Current Cancer Drug Targets 8 3 2008 187 198 (Pubitemid 351688437)
4. C. Blanco-Aparicio, O. Renner, J.F. Leal, and A. Carnero PTEN, more than the AKT pathway Carcinogenesis 28 7 2007 1379 1386 (Pubitemid 47243536)
5. I. Vivanco, and C.L. Sawyers The phosphatidylinositol 3-kinase AKT pathway in human cancer Nature Reviews Cancer 2 7 2002 489 501 (Pubitemid 37328931)
6. M.L. Sulis, and R. Parsons PTEN: from pathology to biology Trends in Cell Biology 13 9 2003 478 483 (Pubitemid 37289398)
7. L. Shayesteh, Y. Lu, W.L. Kuo, R. Baldocchi, T. Godfrey, and C. Collins PIK3CA is implicated as an oncogene in ovarian cancer Nature Genetics 21 1 1999 99 102 (Pubitemid 29036292)
8. J. Woenckhaus, K. Steger, E. Werner, I. Fenic, U. Gamerdinger, and T. Dreyer Genomic gain of PIK3CA and increased expression of p110alpha are associated with progression of dysplasia into invasive squamous cell carcinoma Journal of Pathology 198 3 2002 335 342 (Pubitemid 35277384)
9. J.R. Testa, and A. Bellacosa AKT plays a central role in tumorigenesis Proceedings of the National Academy of Sciences of the United States of America 98 20 2001 10983 10985 (Pubitemid 32928669)
10. R. Katso, K. Okkenhaug, K. Ahmadi, S. White, J. Timms, and M.D. Waterfield Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer Annual Review of Cell and Developmental Biology 17 2001 615 675 (Pubitemid 33096187)
11. S.L. Campbell, R. Khosravi-Far, K.L. Rossman, G.J. Clark, and C.J. Der Increasing complexity of Ras signaling Oncogene 17 11 1998 1395 1413 (Pubitemid 28458409)
12. J.F. Lyons, S. Wilhelm, B. Hibner, and G. Bollag Discovery of a novel Raf kinase inhibitor Endocrine-Related Cancer 8 3 2001 219 225 (Pubitemid 32947644)
13. M. Malumbres, and M. Barbacid RAS oncogenes: the first 30 years Nature Reviews Cancer 3 6 2003 459 465 (Pubitemid 37328850)
14. N. Saxena, S.S. Lahiri, S. Hambarde, and R.P. Tripathi RAS: target for cancer therapy Cancer Investigation 26 9 2008 948 955
15. A. Lievre, J.B. Bachet, D. Le Corre, V. Boige, B. Landi, and J.F. Emile KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer Cancer Research 66 8 2006 3992 3995
16. S.E. Chang, P. Bhatia, N.W. Johnson, P.R. Morgan, F. McCormick, and B. Young Ras mutations in United Kingdom examples of oral malignancies are infrequent International Journal of Cancer 48 3 1991 409 412
17. N. Das, J. Majumder, and U.B. DasGupta Ras gene mutations in oral cancer in eastern India Oral Oncology 36 1 2000 76 80
18. K.C. Bruckman, F. Schönleben, W. Qiu, V.L. Woo, and G.H. Su Mutational analyses of the BRAF, KRAS, and PIK3CA genes in oral squamous cell carcinoma Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics 110 5 2010 632 637
19. W. Qiu, F. Schönleben, X. Li, D.J. Ho, L.G. Close, and S. Manolidis PIK3CA mutations in head and neck squamous cell carcinoma Clinical Cancer Research 12 5 2006 1441 1446
20. G.C. Kostakis, N. Papadogeorgakis, V. Koumaki, S. Kamakari, D. Koumaki, and C. Alexandridis Absence of hotspot mutations in exons 9 and 20 of the PIK3CA gene in human oral squamous cell carcinoma in the Greek population Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics 109 2010 e53 e58
21. K. Kozaki, I. Imoto, A. Pimkhaokham, S. Hasegawa, H. Tsuda, and K. Omura PIK3CA mutation is an oncogenic aberration at advanced stages of oral squamous cell carcinoma Cancer Science 97 12 2006 1351 1358 (Pubitemid 44614987)
22. I. Fenic, K. Steger, C. Gruber, C. Arens, and J. Woenckhaus Analysis of PIK3CA and Akt/protein kinase B in head and neck squamous cell carcinoma Oncology Reports 18 1 2007 253 259
23. Y. Cohen, E. Merhavi-Shoham, R.B. Avraham, S. Frenkel, J. Pe'er, and N. Goldenberg-Cohen Hypermethylation of CpG island loci of multiple tumor suppressor genes in retinoblastoma Experimental Eye Research 86 2 2008 201 206
24. J.D. Carpten, A.L. Faber, C. Horn, G.P. Donoho, S.L. Briggs, and C.M. Robbins A transforming mutation in the pleckstrin homology domain of AKT1 in cancer Nature 448 7152 2007 439 444 (Pubitemid 47123510)
25. K.A. West, J. Brognard, A.S. Clark, I.R. Linnoila, X. Yang, and S.M. Swain Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells Journal of Clinical Investigation 111 1 2003 81 90 (Pubitemid 36134851)
26. E. Massarelli, D.D. Liu, J.J. Lee, A.K. El-Naggar, L. Lo Muzio, and S. Staibano Akt activation correlates with adverse outcome in tongue cancer Cancer 104 11 2005 2430 2436 (Pubitemid 41691564)
27. J. Lim, J.H. Kim, J.Y. Paeng, M.J. Kim, S.D. Hong, and J.I. Lee Prognostic value of activated Akt expression in oral squamous cell carcinoma Journal of Clinical Pathology 58 11 2005 1199 1205 (Pubitemid 41566467)
28. P. Amornphimoltham, V. Sriuranpong, V. Patel, F. Benavides, C.J. Conti, and J. Sauk Persistent activation of the Akt pathway in head and neck squamous cell carcinoma: a potential target for UCN-01 Clinical Cancer Research 10 15 2004 4029 4037 (Pubitemid 38812478)
29. L.H. Saal, S.K. Gruvberger-Saal, C. Persson, K. Lövgren, M. Jumppanen, and J. Staaf Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair Nature Genetics 40 1 2008 102 107
30. Y. Samuels, Z. Wang, A. Bardelli, N. Sillman, J. Ptak, and S. Szabo High frequency of mutations of the PIK3CA gene in human cancers Science 304 5670 2004 554 (Pubitemid 38541907)
31. J.M. Spencer, S.M. Kahn, W. Jiang, V.A. DeLeo, and I.B. Weinstein Activated ras genes occur in human actinic keratoses, premalignant precursors to squamous cell carcinomas Archives of Dermatology 131 7 1995 796 800
32. M. Hoa, S.L. Davis, S.J. Ames, and R.A. Spanjaard Amplification of wild-type K-ras promotes growth of head and neck squamous cell carcinoma Cancer Research 62 24 2002 7154 7156 (Pubitemid 36025228)
33. K.H. Shin, J.M. Kim, K.S. Rho, K.H. Park, J.E. Oh, and B.M. Min Inactivation of the PTEN gene by mutation, exonic deletion, and loss of transcript in human oral squamous cell carcinomas International Journal of Oncology 21 5 2002 997 1001
34. T. Zenz, K. Döhner, T. Denzel, H. Döhner, S. Stilgenbauer, and L. Bullinger Chronic lymphocytic leukaemia and acute myeloid leukaemia are not associated with AKT1 pleckstrin homology domain (E17K) mutations British Journal Haematology 141 5 2008 742 743 (Pubitemid 351667634)
35. D. Malanga, M. Scrima, C. De Marco, F. Fabiani, N. De Rosa, and S. De Gisi Activating E17K mutation in the gene encoding the protein kinase AKT1 in a subset of squamous cell carcinoma of the lung Cell Cycle 7 5 2008 665 669 (Pubitemid 351499006)
36. M.S. Kim, E.G. Jeong, N.J. Yoo, and S.H. Lee Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukemias British Journal of Cancer 98 9 2008 1533 1535 (Pubitemid 351652321)
37. R. Tibes, S.M. Kornblau, Y. Qiu, S.M. Mousses, C. Robbins, and T. Moses PI3K/AKT pathway activation in acute myeloid leukemias is not associated with AKT1 pleckstrin homology domain mutation British Journal Haematology 140 3 2007 344 347
38. D.E. Zilberman, Y. Cohen, N. Amariglio, E. Fridman, J. Ramon, and G. Rechavi AKT1 E17K pleckstrin homology domain mutation in urothelial carcinoma Cancer Genetics and Cytogenetics 191 1 2009 34 37
39. Y. Cohen, B. Shalmon, J. Korach, I. Barshack, E. Fridman, and G. Rechavi AKT1 pleckstrin homology domain E17K activating mutation in endometrial carcinoma Gynecologic Oncology 116 1 2010 88 91
40. H.F. Tu, K.W. Chang, W.F. Chiang, C.J. Liu, E.H. Yu, and S.T. Liu The frequent co-expression of the oncogenes PIK3CA and PAK1 in oral carcinomas Oral Oncology 47 3 2011 211 216